Table 1.

Characteristics of patients with RA and HC.

CharacteristicsRA, n = 235HC, n = 180p
Age, yrs55.2 ± 11.347.4 ± 11.8< 0.0001
Height, m1.65 ± 6.51.68 ± 5.5< 0.0001
Body weight, kg70.7 ± 14.666.4 ± 10.8< 0.0001
Smoking45 (19.3)47 (26.1)0.1
Alcohol consumption165 (70.5)168 (93.3)< 0.0001
Living in a partnership179 (77.5)150 (85.2)0.049
No. pregnancies2.1 ± 1.291.72 ± 1.320.048
No. children1.78 ± 1.081.43 ± 1.050.023
Level of education< 0.0001
  Compulsory education49 (21.3)7 (3.9)
  Professional diploma110 (48.0)26 (14.6)
  Higher level (college/university)70 (30.5)144 (81.3)
Working capacity100 (43.3)139 (78.5)< 0.0001
Joint replacement35 (14.9)5 (2.8)< 0.0001
Surgery on the spine16 (7)3 (1.7)0.011
RF-positive161 (71.9)
ACPA-positive135 (63.4)
csDMARD184 (78.3)
bDMARD129 (45.5)
Both csDMARD and bDMARD76 (32.3)
No DMARD at all20 (8.5)
Depression, n66/223a21/169a0.001
  BDI categories
    Mild49 (22)19 (11)
    Moderate14 (6)2 (1)
    Severe3 (1)0 (0)
Comorbidities
  Diabetes5 (2.2)2 (1.1)0.418
  High blood pressure49 (22.4)26 (14.4)0.044
  Coronary heart disease3 (1.6)1 (0.6)0.364
  Congestive heart failure5 (2.4)0 (0.0)0.039
  Peripheral arterial occlusive disease13 (6.7)7 (4.02)0.263
  Mucosal dryness44 (21.9)12 (6.9)< 0.0001
  • Data are given in mean ± SD for continuous variables or n (%) for binary variables, unless otherwise specified.

  • a Data available for analysis; owing to a varying number of answers in the different characteristics, the total scores vary within the questionnaire. RA: rheumatoid arthritis; HC: healthy controls; RF: rheumatoid factor, ACPA: anticitrullinated protein antibodies; DMARD: disease-modifying antirheumatic drugs; csDMARD: conventional synthetic DMARD; bDMARD: biologic DMARD; BDI: Beck Depression Inventory.